The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Alireza Ghodsi
No Relationships to Disclose
 
Ridvan Demirci
No Relationships to Disclose
 
Roman Gulati
Employment - Linda Fukuda Family Dentistry (I)
Patents, Royalties, Other Intellectual Property - Royalty for textbook "Statistics for Health Data Science"
(OPTIONAL) Uncompensated Relationships - American Cancer Society
 
Peter Nelson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Genentech; Janssen Oncology; Pfizer
Research Funding - Auron, Inc (Inst); Janssen Oncology
Expert Testimony - Venable
 
Ruben Raychaudhuri
No Relationships to Disclose
 
Heather Cheng
Consulting or Advisory Role - Janssen Oncology
Research Funding - Clovis Oncology (Inst); Janssen (Inst); Phosplatin Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Rajitha Sunkara
No Relationships to Disclose
 
Hiba Khan
Research Funding - Amgen (Inst)
 
Rosa Nadal
Research Funding - Amgen - Local PI (Inst); Promicell (Inst)
 
Andrew Hsieh
Honoraria - Hotspot Therapeutics
Research Funding - Denali Therapeutics
Patents, Royalties, Other Intellectual Property - MTOR modulators and uses thereof Patent number: 9629843; USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT Publication number: 20140288097
 
Petros Grivas
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Foundation Medicine; Gilead Sciences; Janssen; Lilly; Merck; Pfizer; Replimune; Roche; Strata Oncology; Tyra Biosciences; Urogen pharma
Research Funding - Acrivon Therapeutics (Inst); ALX Oncology (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Robert Montgomery
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; Janssen Scientific Affairs
Research Funding - Clovis Oncology (Inst); Inmune Bio; Janssen Oncology (Inst); Merck/Genentech
 
Todd Yezefski
Consulting or Advisory Role - Dendreon
 
Evan Yu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Johnson and Johnson; Lantheus Medical Imaging; Merck; Novartis; Tolmar
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Pfizer (Inst); Tyra Biosciences (Inst)
 
Michael Schweizer
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; FibroGen; Janssen; K36 Therapeutics; Pfizer
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Epigenetix (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oric Pharmaceuticals (Inst); Pfizer (Inst); Roche (Inst); SignalOne Bio (Inst); Xencor (Inst); Zenith Epigenetics (Inst)
 
Delphine Chen
Honoraria - GE Healthcare
Research Funding - Telix Pharmaceuticals (Inst); United Imaging (Inst)
Patents, Royalties, Other Intellectual Property - WO 201503526 A1 Mach RH, Chu W, Zhou D, Michel LS, Chen DL. Radiolabeled tracers for poly(adp-ribose)polymerase-1 (PARP-1), methods and uses therfor
Travel, Accommodations, Expenses - GE Healthcare
 
Amir Iravani
Consulting or Advisory Role - Lantheus Medical Imaging; Novartis